Articles Tagged With: sars-cov-2
-
Resistance of SARS-CoV-2 Variants to Monoclonal Antibodies
Prevalent SARS-CoV-2 variants are persistently resistant to therapeutic and prophylactic monoclonal antibodies but remain susceptible to nirmatrelvir/ritonavir, remdesivir, and molnupiravir.
-
‘Vast Majority’ of Mild SARS-CoV-2 Cases Clear Long COVID by One Year
A recent Israeli study tries to deflate the haunting specter of long COVID by examining the association of mild SARS-CoV-2 infection and long-term health outcomes.
-
COVID-19: Beware Remdesivir Resistance
Researchers reported two immunosuppressed renal transplant recipients with persistent SARS-CoV-2 infection in association with the new emergence of mutations in RNA-dependent RNA polymerase after remdesivir treatment.
-
Resistance of SARS-CoV-2 Variants to Monoclonal Antibodies
Prevalent SARS-CoV-2 variants are increasingly resistant to therapeutic and prophylactic monoclonal antibodies but remain susceptible to Paxlovid, remdesivir, and molnupiravir.
-
Special Report: Humbled CDC Seeks Reinvention, Culture Change
The CDC has taken responsibility for its haphazard response to the COVID-19 pandemic in the United States, admitting to mistakes and miscalculations that often directly affected healthcare workers.
-
Myopathy Is Associated with Post-COVID-19 Fatigue
Prolonged fatigue after COVID-19 infection may be associated with evidence of myopathy, based on physical examination, electromyography, and muscle biopsy.
-
Two-Dose Novavax Added to List of U.S. COVID-19 Vaccines
The FDA issued an emergency use authorization for the fourth vaccine.
-
Outpatient Management of COVID-19
The COVID-19 pandemic continues to be a major public health concern. The availability of new therapies, as well as their use, continues to be shrouded in confusion. This discussion provides a brief clinical overview of COVID-19, followed by a focus on outpatient management and therapy based on our current understanding and available therapies.
-
An Epic Battle: SARS-CoV-2 vs. the Human Immune System
Penny Moore, PhD, an HIV researcher for about two decades, has redeployed much of her research to measure humoral immune response to SARS-CoV-2 infection and vaccination.
-
Long COVID Patients Report Symptoms 15 Months Later
Brain fog, dizziness, and more side effects can linger for many months after initial SARS-CoV-2 infection.